Intracellular Delivery Focus Targeted outreach around Feldan Shuttle, the company’s core technology for intracellular delivery, highlighting opportunities to collaborate on therapies for respiratory and skin diseases where intracellular access is a key differentiator.

Clinical Stage Opportunities Position Feldan as a partner for late-stage development and potential co-development in intracellular delivery modalities, leveraging their clinical-stage status to align with pharma sponsors seeking translational and translational-focused programs.

Strategic Partnerships Leverage recent investments and board-level signals (e.g., Zynext Ventures funding) to approach Feldan about strategic alliances, licensing, or equity-backed collaborations that expand their pipeline and accelerate market-readiness.

Funding Trajectory Capitalize on their Series B funding history and CF-focused grant interests to propose grant-ready collaborations, funded research milestones, and milestone-based partnerships that reduce risk for Feldan.

Therapeutic Focus Fit Emphasize applications in respiratory and dermatological diseases where intracellular delivery could unlock new modalities, aligning product opportunities with Feldan’s stated disease targets and scientific strengths.